Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REGENERON PHARMACEUTICALS, INC. | Director | Common Stock | 1,382 | $1.31 M | $951.26 | Jan 2, 2024 | Direct |
REGENERON PHARMACEUTICALS, INC. | Director | Non-Qualified Stock Option (right to buy) | 1,607 | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
REGN | REGENERON PHARMACEUTICALS, INC. | Jan 2, 2024 | 5 | -567,525 | 4 | Jan 4, 2024 | Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Oct 13, 2023 | 3 | -458,080 | 4 | Oct 17, 2023 | Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Jan 3, 2023 | 2 | 0 | 4 | Jan 5, 2023 | Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Mar 16, 2022 | 3 | -566,160 | 4 | Mar 18, 2022 | Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Jan 3, 2022 | 2 | 0 | 4 | Jan 5, 2022 | Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Sep 13, 2021 | 6 | -258,082 | 4 | Sep 15, 2021 | Director |